Results 301 to 310 of about 1,218,074 (349)
Some of the next articles are maybe not open access.
Quinapril in Chronic Heart Failure
American Journal of Hypertension, 1990Angiotensin converting enzyme inhibitors are now firmly established in the treatment of patients with chronic heart failure (CHF). Their beneficial acute and chronic hemodynamic effects are not associated with reflex tachycardia or drug tolerance. Angiotensin converting enzyme inhibitors produce symptomatic improvement and improve exercise capacity in ...
D B Northridge, Henry J. Dargie
openaire +3 more sources
Insomnia and chronic heart failure
Heart Failure Reviews, 2008Insomnia is highly prevalent in patients with chronic disease including chronic heart failure (CHF) and is a significant contributing factor to fatigue and poor quality of life. The pathophysiology of CHF often leads to fatigue, due to nocturnal symptoms causing sleep disruption, including cough, orthopnea, paroxysmal nocturnal dyspnea, and nocturia ...
Barbara Phillips +3 more
openaire +3 more sources
Economics of chronic heart failure
European Journal of Heart Failure, 2001AbstractChronic heart failure (CHF) is now recognized as a major and escalating public health problem. The costs of this syndrome, both in economic and personal terms, are considerable. The prevalence of CHF is 1–2% and appears to be increasing, in part because of ageing of the population.
David R. Murdoch +2 more
openaire +2 more sources
2009
Heart failure is the leading cause of hospitalization in the Medicare age group. The prognosis for established heart failure in persons over age 65 is poor, with 5-year survival rates of less than 50% in both men and women. The pharmacotherapy of systolic heart failure is well established, with angiotensin-converting enzyme inhibitors and beta ...
Michael W. Rich, Christopher L. Holley
openaire +2 more sources
Heart failure is the leading cause of hospitalization in the Medicare age group. The prognosis for established heart failure in persons over age 65 is poor, with 5-year survival rates of less than 50% in both men and women. The pharmacotherapy of systolic heart failure is well established, with angiotensin-converting enzyme inhibitors and beta ...
Michael W. Rich, Christopher L. Holley
openaire +2 more sources
Testosterone in Chronic Heart Failure
2008Chronic heart failure is common and can be described as a syndrome characterized by impairment of cardiac function associated with a maladaptive metabolic and neurohormonal axis. The thesis that testosterone replacement therapy may be helpful as a treatment for chronic heart failure may seem at first to be unlikely.
KS Channer, Chris J. Malkin, T. H. Jones
openaire +3 more sources
Homocysteine in Chronic Heart Failure
Clinical Laboratory, 2015Hyperhomocysteinemia (HHcy) is a risk factor for cardiovascular disease. Homocysteine (Hcy) can generate reactive oxygen species. Oxidative stress enhances the progression of cardiovascular diseases and has long been implicated in chronic heart failure (CHF).
Joelle Fourcade +5 more
openaire +2 more sources
[ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?]
Giornale italiano di cardiologia, 2022G. Sinagra, L. Pagura, D. Stolfo
semanticscholar +1 more source
Erythropoietin in Chronic Heart Failure
Congestive Heart Failure, 2007In patients with chronic heart failure (CHF), anemia is common and is associated with adverse outcome. Correction of anemia by erythropoiesis‐stimulating proteins would thus seem attractive. Endogenous erythropoietin (Epo) levels are increased in CHF and are associated with severity of the disease and with increased mortality.
Anne M. S. Belonje +3 more
openaire +2 more sources
Pathophysiology of chronic heart failure
The American Journal of Medicine, 2001Heart failure is a changing paradigm. The hemodynamic model, which served our needs well from the 1950s through the early 1980s, has now been largely abandoned, except for the management of decompensated patients in the hospital. The pathophysiology is exceedingly complex and involves structural changes, such as loss of myofilaments, apoptosis and ...
openaire +3 more sources